CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
931-945 of 1225
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD
John McMurray, OBE, BSc, MB ChB (Hons), MD, FRCP, FRSE, FMedSci, FESC, FACC, FAHA, FJCS, FHFA, FHFSA, FBSH
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
CME/CEUnderstanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
Joseph F. Goldberg, MD
Empowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
CME/CEEmpowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
Joyce O'Shaughnessy, MD
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
MinuteCE®A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
James Burton, DM, FRCP
Aaron Wong, MD
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
MinuteCE®Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Gianluigi Savarese, MD
Summarizing multidisciplinary strategies: Where do we go from here?
MinuteCE®Summarizing multidisciplinary strategies: Where do we go from here?
Gianluigi Savarese, MD, PhD, FESC, FHFA
- advertisement
Gianluigi Savarese, MD, PhD, FESC, FHFA
James Burton, DM, FRCP
Aaron Wong, MD
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
CME/CENew Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Carolyn Lam, MD, PhD
Scott Solomon, MD
Mikhail Kosiborod, MD
CETP inhibition: Lessons from two decades of clinical trials
MinuteCE®CETP inhibition: Lessons from two decades of clinical trials
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
CME/CEPartnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
MinuteCE®A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
Erin Michos
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
MinuteCE®What do we know now that could have changed the history of CETP inhibition?: genetics and biology
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
- advertisement
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin Michos
Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
CME/CE Broadcast ReplayPulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
Martha Kingman, DNP, FNP-C
Susanne McDevitt, DNP, ACNP-BC
Perry Elliott, MD
Roberto Barriales-Villa, MD, PhD
Iacopo Olivotto, MD
